Taken together, our data define a functional, requisite role for increased G6PD expression in maintaining resistance to 8-NH2-Ado/8-Cl-Ado but suggest that co-regulation of an unidentified cellular process in addition to elevated PPP flux is necessary to induce de novo drug resistance in MM and MCL cells. The gene discussed is G6PD; the disease is Miyoshi myopathy.